BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11828862)

  • 1. Early antiretroviral therapy of HIV-infected infants in resource-limited countries: possible, feasible, effective and challenging.
    Becquet R; Mofenson LM
    AIDS; 2008 Jul; 22(11):1365-8. PubMed ID: 18580616
    [No Abstract]   [Full Text] [Related]  

  • 2. The emergence of drug resistant HIV variants and novel anti-retroviral therapy.
    Paydary K; Khaghani P; Emamzadeh-Fard S; Alinaghi SA; Baesi K
    Asian Pac J Trop Biomed; 2013 Jul; 3(7):515-22. PubMed ID: 23835806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on HIV-1 antiretroviral drug resistance.
    Iyidogan P; Anderson KS
    Viruses; 2014 Oct; 6(10):4095-139. PubMed ID: 25341668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 DNA drug resistance testing to guide successful suppression of low-level viraemia: a case report.
    Cao B; Liu M; Zhu R; Yuan T; E'er A; Song S; Wang T; Zhong L
    Sex Transm Infect; 2023 Dec; 99(8):575. PubMed ID: 37604681
    [No Abstract]   [Full Text] [Related]  

  • 5. 2022 update of the drug resistance mutations in HIV-1.
    Wensing AM; Calvez V; Ceccherini-Silberstein F; Charpentier C; Günthard HF; Paredes R; Shafer RW; Richman DD
    Top Antivir Med; 2022 Oct; 30(4):559-574. PubMed ID: 36375130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update.
    Granich R; Crowley S; Vitoria M; Smyth C; Kahn JG; Bennett R; Lo YR; Souteyrand Y; Williams B
    Curr Opin HIV AIDS; 2010 Jul; 5(4):298-304. PubMed ID: 20543604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1.
    Di Teodoro G; Pirkl M; Incardona F; Vicenti I; Sönnerborg A; Kaiser R; Palagi L; Zazzi M; Lengauer T
    Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38775719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapy.
    Shafer RW; Nguyen DP; Fessel WJ
    MedGenMed; 2006 Aug; 8(3):32. PubMed ID: 17406166
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015-2021.
    Van Praet JT; Serrien B; Ausselet N; Darcis G; Demeester R; De Munter P; De Scheerder MA; Goffard JC; Libois A; Messiaen P; Yombi JC; Van Beckhoven D;
    J Acquir Immune Defic Syndr; 2023 Jun; 93(2):e4-e5. PubMed ID: 36787727
    [No Abstract]   [Full Text] [Related]  

  • 10. Palliative care for HIV disease in the era of highly active antiretroviral therapy.
    Greenberg B; McCorkle R; Vlahov D; Selwyn PA
    J Urban Health; 2000 Jun; 77(2):150-65. PubMed ID: 10855997
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO Documents Rising Resistance to First-Line HIV Drug.
    Harris E
    JAMA; 2024 Apr; 331(16):1355. PubMed ID: 38578630
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of backward mutations on the within-host dynamics of HIV-1.
    Kitayimbwa JM; Mugisha JY; Saenz RA
    J Math Biol; 2013 Nov; 67(5):1111-39. PubMed ID: 22955525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing and managing antiretroviral drug resistance.
    Kuritzkes DR
    AIDS Patient Care STDS; 2004 May; 18(5):259-73. PubMed ID: 15186710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy in HIV-infected infants and children.
    Marón G; Gaur AH; Flynn PM
    Pediatr Infect Dis J; 2010 Apr; 29(4):360-3. PubMed ID: 20351530
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
    Alessandri-Gradt E; Morgand M; Delaugerre C; Peytavin G; Sellier P; Simon F; Plantier JC
    AIDS; 2015 Jun; 29(10):1271-3. PubMed ID: 26035328
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral therapy for HIV: drug resistance and sequencing.
    Burkle WS
    J Assoc Nurses AIDS Care; 2002; 13(1):76-80. PubMed ID: 11828862
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.